Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma

doi:10.3748/wjg.v17.i32.3709

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3315)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

299

HTML

2588

Figures (1-2)

240

Tables (1-5)

188

Sum=3315

Aug 28, 2011 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2011; 17(32): 3709-3715
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709

Table 4 Clinicopathological characteristics of patients who underwent curative surgery for hepatocellular carcinoma

	Non-HT group	HT group(n = 83)	P-value(Non-HT vs HT)	Non-HT group
	(n = 193)	HT group(n = 83)	P-value(Non-HT vs HT)	Non-transfusion group(n = 78)	AT group(n = 115)	P-value(Non-transfusion vs AT)
Clinical factors
Gender (male/female)	156/37	70/13	0.488	63/15	93/22	0.986
Age (yr)¹	62 ± 8	61 ± 9	0.115	62 ± 8	61 ± 9	0.878
HBs-Ag (±)	163/30	67/16	0.445	Nov-67	96/19	0.649
Anti-HCV Ab (±/unknown)	62/127/4	31/51/1	0.426	21/54/3	41/73/1	0.254
Child-Pugh classification (A/B)	161/32	65/18	0.262	66/12	95/20	0.833
Preoperative Hb (g/dL)¹	13.5 ± 1.5	13.4 ± 1.6	0.425	12.8 ± 1.8	14.1 ± 1.1	< 0.0001
Tumor-related factors
Number of tumors (single/multiple)	147/46	64/19	0.866	62/16	85/30	0.372
Maximum tumor size (cm)¹	3.5 ± 2.4	4.8 ± 3.7	0.000	3.3 ± 2.2	3.6 ± 2.4	0.287
Vascular invasion (±)	172/21	70/13	0.268	73/5	99/16	0.101
Histological grade (I, II/III, IV/unknown)	89/83/21	33/41/9	0.304	36/34/8	53/49/13	0.412

¹Data are expressed as number of patients and mean ± standard deviation. HBs-Ag: Hepatitis B surface antigen; Anti-HCV Ab: Anti-hepatic C virus antibody; Hb: Hemoglobin; AT: Autologous transfusion; HT: Homologous transfusion.

Citation: Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011; 17(32): 3709-3715
URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3709.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i32.3709